Skip to main content
. 2020 Feb 3;12(2):341. doi: 10.3390/cancers12020341

Figure 4.

Figure 4

Figure 4

Figure 4

Distribution of pooled sensitivity and specificity, and their predicted posteriors in the Bayesian meta-analyses. (A). miRNA-186-5p showed pooled sensitivity: 0.73, prediction sensitivity: 0.74, pooled specificity 0.73 and prediction specificity: 0.74. (B). miRNA-30e-5p showed pooled sensitivity: 0.65, prediction sensitivity: 0.66, pooled specificity 0.6 and prediction specificity: 0.61. (C). miRNA-10b-5p showed pooled sensitivity: 0.63, prediction sensitivity: 0.64, pooled specificity: 0.6 and prediction specificity: 0.6). (D). miRNA-21-5p showed pooled sensitivity: 0.77, prediction sensitivity: 0.78, pooled specificity: 0.72 and prediction specificity: 0.73. (E). miRNA-31-5p showed pooled sensitivity: 0.77, prediction sensitivity: 0.77, pooled specificity: 0.63 and prediction specificity: 0.64. (F). Analyses of the multiple miRNA biomarkers revealed 0.85 for pooled sensitivity, 0.9 for pooled specificity, 0.89 for prediction sensitivity and 0.93 for the prediction specificity.